T32 Postdoctoral Trainee - Carolina Cancer Nanotechnology Training Program (Postdoctoral Scholar)

A global higher education leader in innovative teaching, research and public service, the University of North Carolina at Chapel Hill consistently ranks as one of the nation's top public universities and is among is the top ten research universities in the nation for federal research expenditures as well as for federally funded social and behavioral sciences research and development.

Here at Carolina, our highly skilled postdocs play a vital role in our research enterprise and towards our overall commitment to research excellence. Across many disciplines, postdocs contribute to the intellectual vitality of the University. They provide innovative ideas and perspectives, foster a stimulating research environment and advance knowledge within their fields. Postdocs are crucial members of our scientific research workforce, contributors to our research outputs and an important reason why Carolina is one of the leading public research institutions in the country.

UNC-Chapel Hill offers postdocs comprehensive medical and vision coverage, paid leave, and benefits and services that support professional development and a healthy work/life balance. Chapel Hill regularly ranks as one of the best college towns and best places to live in the United States, a reputation guided by the diverse social, cultural, recreation and professional opportunities that span the campus and community.

The UNC Eshelman School of Pharmacy (www.pharmacy.unc.edu) is one of six health science schools (Pharmacy, Nursing, Dentistry, Social Work, Public Health, Medicine) at the University of North Carolina at Chapel Hill and is one of the oldest health science academic programs at Chapel Hill. The School teaches approximately 600 PharmD students and 145 graduate students. The School has built a reputation for its continued pursuit of excellence, rigorous education and training programs, cutting-edge multidisciplinary research, progressive pharmacy practices, efficient business operations, and its outstanding faculty, staff, and students. The School was named the number one School of Pharmacy in the U.S. by the U.S. News and World Report. The School has experienced unprecedented growth and success and continues to strategically position itself for sustained impact, as articulated in the School's Strategic Plan (https://pharmacy.unc.edu/about/oe/strategic-plan/).

Our Vision is to be the global leader in pharmacy and pharmaceutical sciences. Our Mission is to prepare leaders and innovators to solve the world's most pressing health care challenges. We are Advancing Medicine for Life through innovation and collaboration in pharmacy practice, education, research, and public service.

The Carolina Cancer Nanotechnology Training Program is a 24-36-month mentored postdoctoral training program that is offered at The University of North Carolina Chapel Hill ( UNC Chapel Hill) with focus area of research on cancer nanotechnology. This program includes 22 faculty members representing eleven departments in three Schools, including physical, and material scientists, biomedical engineers, basic biomedical scientists, pharmaceutical scientists, and clinician-scientists, all of whom have demonstrated strong interests and capabilities to work at the interface between nanoscience and cancer. These individuals will serve as mentors to trainees, utilizing two broad approaches. The first approach involves active co-mentorship of the trainee's research project over a period of two years. In each case there will be a physical scientist and a biomedical scientist acting in tandem to guide trainee research. It is expected that this approach will provide unique multi-faceted training experience leading to significant contributions to cancer nanotechnology. The second approach involves trainee participation in workshops and courses that will broaden their knowledge and conceptual understanding of all areas of cancer nanotechnology. The topics of these workshops will reflect many of the major themes of the Alliance for Nanotechnology in Cancer. In addition to activities focused on postdoctoral researchers, the C- CNTP will also embark on a broadly based outreach program to disseminate concepts concerning cancer nanotechnology both within the university community and to the public at large.

Postdoctoral trainee will have completed highly relevant doctoral training in medical, pharmacy, chemistry, biomedical sciences, nanotechnology and cancer biology, or related area and awarded a Ph.D., M.D. or M.D./Ph.D.

All applicants must be either US citizens, non-citizen nationals or permanent residents.

- Full understanding of framing research question, research design and methods, and project implementation.
- Demonstrated proficiency in scientific/manuscript writing, grant writing, poster and oral presentations.
- Preferred candidates will have strong publication record and demonstrated experience in research study design and project implementation.

Apply online at, https://unc.peopleadmin.com/postings/281232 with the following documents:
1. CV/resume
2. Cover letter
3. A two-page research statement describing your research interests, research experience, career goals and clinical experience (if any).
4. List of at least three professional references with their full contact information.

For information on UNC Postdoctoral Benefits and Services click here

If you experience any problems accessing the system or have questions about the application process, please contact the University's Office of Postdoctoral Affairs at (919) 962-9982 or send an email to opahr@unc.edu.

Please note: The Office of Postdoctoral Affairs will not be able to provide specific updates regarding position or application status.

The University is an equal opportunity, employer and welcomes all to apply without regard to age, color, gender, gender expression, gender identity, genetic information, national origin, race, religion, sex, or sexual orientation. We encourage all qualified applicants to apply, including protected veterans and individuals with disabilities.